Africa: Is the WHO and global fund supporting sub-standard treatment?

“At least tens of thousands of children die every year” because the World Health Organisation and the Global Fund for AIDS, Tuberculosis, and Malaria (GFATM) continue to fund (or support the funding) the purchase of old drugs by African countries rather than the newer, more effective and dramatically more expensive artemisinin-class combination therapies (ACT), according to an editorial “viewpoint” published in the January 17th issue of The Lancet. The editorial, written by academic malaria specialists and some researchers in the developing world accuses both organisations of “medical malpractice” and blames them for caving into pressure from donor governments such as the USA, whose aid officials say that ACT is too expensive.